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A hallmark of the mammalian 
circadian timing system is synchro-
nization of physiology and behavior, 
but when this synchronization is 
disturbed, chronic diseases such as 
metabolic syndrome and depression 
may develop. Three new studies 
show that nuclear receptors of the 
Rev-Erb family impact the circadian 
oscillator and its metabolic output 
and this can be modified with specific
agonists. Hence, resynchronization of 
metabolic pathways by manipulation 
of the circadian oscillator using REV-
ERB-specific agonists may represent 
a feasible therapeutic concept to 
target diseases rooted in a misaligned 
circadian system.
The circadian clock simulates the 
external light:dark cycle in essentially 
all body cells [1]. The coarse separation 
into activity and rest phase optimally 
synchronizes anabolic and catabolic 
pathways not only in individual cells, 
but also in the surrounding tissue and 
even the entire organism. A paired 
neuronal structure in the hypothalamus, 
the so-called Suprachiasmatic nuclei 
(SCN), keep the organism in resonance 
with the environment. This master 
clock converts the external light:dark 
information into hormonal and electro-
physiological signals synchronizing all 
other cell-autonomous circadian clocks 
in the periphery. Like this stable phase-
relationships between all of the organs 
are established. By de¿nition (‘circa 
diem’ translates to ‘about a day’) circa-
dian clocks provide a period length of 
about a day. However, this slight daily 
imprecision is not a problem, because 
sophisticated regulatory mechanisms, 
e.g., based on light input or food uptake, 
provide suf¿cient Àexibility to the clock 
mechanism to readjust every day to the 
environment.
Many diseases may be related to 
disturbances of speci¿c metabolic or 
physiological pathways. For instance, 
in metabolic syndrome the balance 
between the energy-generating glucose 
metabolism and the energy-storing 
lipid metabolism is disturbed [2]. On 
the other hand, de-synchronization of 
hormone secretion and clearance aggra-
vates neuropsychiatric disorders such 
as seasonal affected disorder (SAD), 
depression or bipolar disorder [3]. The 
¿nding that strict daily routines of sleep-
ing and eating times, or light therapy can 
ameliorate to a certain degree these neu-
ropsychiatric disorders [4] highlights 
the importance of the circadian system 
to maintain the normal state. Hence, 
drugs that readjust the synchronizing 
properties of the circadian clock would 
be beneficial. For example, lithium 
is used to treat bipolar disorder and 
impacts various molecular pathways 
including components of the circadian 
clock [5]. 
At the heart of the circadian clock 
is a molecular oscillator based on tran-
scriptional and post-translational feed-
back loops [1]. BrieÀy, a heterodimer 
composed of BMAL and CLOCK (or 
NPAS2 in the brain) activates transcrip-
tion of two sets of repressors (blue line; 
Figure 1). The ¿rst set (i.e., Per and Cry) 
feeds back via E-box motifs (black box-
es) after a certain delay on its own syn-
thesis (pink lines) and these consecutive 
cycles of activation and repression cre-
ate transcriptional rhythms of about 24 
h. The second set was thought to solely 
regulate rhythmic accumulation of the 
Bmal1, Clock and Npas2 genes (red 
lines) via RORE motifs (white boxes). 
This second, stabilizing feedback loop 
relies on alternate repression by REV-
ERBĮ and activation by RORĮ (not 
shown). Input factors such as light (via 
induction of Per genes) or food uptake 
(via metabolism) affect the phase of the 
system (grey lines). Circadian output 
target genes regulating for example key 
enzymes of metabolic pathways can be 
either directly coupled to the molecu-
lar oscillator via E-box and/or RORE 
motifs, or via rhythmically expressed 
transcription factors as intermediates. 
Among the different families of tran-
scriptional regulators, members of the 
family of nuclear receptors link the cir-
cadian timing system with metabolism 
[6, 7]. In this fashion, tissue-speci¿c 
intertwined networks of gene expres-
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sion are generated. This is the base for 
the temporal synchronization of the 
multiple metabolic pathways.
Experiments by Bugge et al. [8] and 
Cho et al. [9] combining chromatin-im-
munoprecipitation (ChIP)-sequencing 
with powerful knockout animal systems 
shed new light on the function of both 
nuclear receptors of the Rev-Erb fam-
ily within the circadian transcriptional 
network. Surprisingly, many new RORE 
motifs were identi¿ed in core circadian 
oscillator genes (Figure 1) and tran-
scriptome analysis of Rev-Erb-de¿cient 
mice revealed that the expression of 
these genes was actually affected. 
Hence, the REV-ERB nuclear receptors 
have a more prominent function within 
the circadian oscillator than previously 
thought, which became apparent only 
after the inactivation of both Rev-ǼrbĮ 
and ȕ isoforms. Mice lacking both 
isoforms displayed a shorter circadian 
rhythm, which resembles mice de¿cient 
in other circadian oscillator components. 
Interestingly, the lipid metabolism, and 
to some extent cholesterol and bile acid 
production, were severely affected, with 
the liver displaying a typical lipid over-
storage phenotype, i.e., hepatosteatosis. 
As conclusion, the balance of lipid and 
glucose metabolism is disturbed in these 
animals. Considering the fact that these 
nuclear receptors impact circadian os-
cillator and output functions and that at 
least REV-ERBĮ readjusts its phase in 
response to external inÀuences on the 
circadian timing system [10], targeted 
activation of these factors using agonists 
may improve coordination of metabolic 
pathways.
Solt et al. [11] now identi¿ed a new 
class of agonists for nuclear receptors of 
the Rev-Erb family. In vitro, they bound 
speci¿cally and with high af¿nity, and 
suppressed circadian reporter genes in 
cultured cells or SCN explants. In vivo, 
administration of these drugs at the 
peak of REV-ERB activity suppressed 
circadian locomotor activity and REV-
ERB target gene expression. Hence, 
these drugs overcame the blood-brain 
barrier to exert their function even in the 
SCN. Surprisingly, the activity of these 
drugs was stronger in the absence of 
light but it was not determined whether 
this was due to a faster clearance of 
these drugs from the circulation in the 
presence of light, or due to competi-
tion of their action with the light input 
pathway because they mimic input 
function (Figure 1). In addition, these 
drugs increased fatty acid and glucose 
oxidation, while reducing the amount 
of lipogenesis and bile acid synthesis. 
As a consequence, treated mice became 
leaner and were more resistant to the 
detrimental effects of high-fat diet. In-
terestingly, these drugs reduced weight 
gain in obese mice that lack leptin, 
indicating that the newly discovered 
REV-ERB agonists affect at least par-
tially metabolic pathways downstream 
or independent of leptin. Taken together, 
speci¿c agonists for nuclear receptors of 
the REV-ERB family hold the potential 
to resynchronize metabolic pathways in 
living organisms. Potential applications 
concern metabolic syndrome, Jet-lag 
(i.e., desynchronization of SCN and 
peripheral clocks), and possibly neu-
ropsychiatric disorders. Future studies 
will have to address the effect of these 
drugs on the central nervous system, 
especially whether and how sleep- and 
mood-related behaviors are affected. 
It will be challenging and exciting 
to translate basic research performed 
in mice to the clinic for treatment of 
patients.
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